SCHNEYER MARK C. (Chief Financial Officer) sold 7.5% of their position (3.50K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $82.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/16/2025ACC: 0001899977-25-000004
Officer· Chief Financial Officer
Since Dec 2021
+3.32K
Net shares
Net buyer
$82.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
6.82K acquired · 3.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.82K
Price / share
—
Trade value
—
% of position
17.0%
9/12/2025
40.13K→46.95K
Common Stock
Direct
Shares
−3.50K
Price / share
$23.65
Trade value
$82.73K
% of position
7.5%
9/15/2025
46.95K→43.45K
Total
Net shares
+3.32K
Net value
-$82.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2025 | A · Award | +6.82K | — | — | 17.0% | 40.13K | 46.95K |
| Common Stock Direct | 9/15/2025 | S · Sale | −3.50K | $23.65 | $82.73K | 7.5% | 46.95K | 43.45K |
| Total | +3.32K | -$82.73K | ||||||
Derivative Transactions0
No derivative transactions reported